Blumenthal Nordrehaug & Bhowmik Files Brief Seeking to Stop Metropolitan Water District from Fluoridating Drinking Water with a Drug (HFSA) Not Approved by the FDA

Share Article

Lawyers at Blumenthal Nordrehaug & Bhowmik File Brief Opposing Metropolitan Water District's motion to dismiss a highly contested lawsuit involving the use of a drug that is not approved by the FDA in public drinking water.

The action of the Metropolitan Water District of adding a drug (HFSA) to our drinking water for medical purposes without first obtaining FDA approval of this drug for such purposes is illegal and needs to be stopped

On November 23, 2011, the attorneys at Blumenthal Nordrehaug & Bhowmik filed a brief opposing the Metropolitan Water District’s motion to dismiss a lawsuit alleging that the Metropolitan Water District of Southern California is distributing a drug through the public water systems despite the fact that the drug has not been approved by the FDA to fluoridate our drinking water to fight tooth decay. Foli v. Metropolitan Water District is currently pending in the Federal District Court for the Southern District of California as Case No. 11CV1765 JLS (BLM).

According to the opposition filed by the California attorneys at Blumenthal, Nordrehaug & Bhowmik, “this action is brought to seek redress for the unlawful and unconstitutional medication of Plaintiffs by Defendant Metropolitan Water District of Southern California using an unapproved drug.” Specifically, the lawsuit seeks to stop the Water District’s alleged practice of “injecting hydrofluosilicic acid into the water supply for the purpose of treating disease and dental cavities” on the basis that “Hydrofluosilicic acid has never been approved by the United States Food and Drug Administration for the treatment of disease or dental cavities.” The attorneys argue in the opposition that the Water District's use of a drug not approved by the FDA to fight tooth decay violates the United States Food and Drug Administration Act.

When asked about the lawsuit, the managing partner of the law firm for the plaintiffs, Norm Blumenthal, stated: “"The action of the Metropolitan Water District of adding a drug (HFSA) to our drinking water for medical purposes without first obtaining FDA approval of this drug for such purposes is illegal and needs to be stopped."

Blumenthal, Nordrehaug & Bhowmik is a California contingency fee law firm that represents employees and consumers in individual and class action lawsuits against companies that violate state and/or federal laws.

# # #

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Norm Blumenthal
Visit website